Clinical Investigation of Sensovisc

This clinical investigation aims to investigate the safety and performance of Sensovisc. Sensovisc is used to reduce osteoarthritis (OA) related pain in the joints by supporting synovial fluid by intra-articular injection and allowing the synovial fluid to restore its viscoelastic properties. It increases the joint mobility by reducing or eliminating the pain. This Clinical Investigation was designed as a cross-sectional, interventional, and prospective study.

NCT Number	NCT07237711
Lead Sponsor	Ankara City Hospital Bilkent Collaborators: İstem Medikal Tıbbi Cihaz ve Sanayi Ticaret Anonim Şirketi
Conditions	Osteo Arthritis of the Knee
Enrollment	75 participants
Start Date	2025-11-25
Primary Completion	2026-08-25 (estimated)
Study Completion	2026-11-25 (estimated)
Updated on ClinicalTrials.gov	2025-11-20